51 search results for: symposium

Epidemiology and Pathophysiology of AD in Children
Dermatology
Epidemiology and Pathophysiology of AD in Children
expert video

In this expert interview video focusing on topics from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Christine Bangert discusses the epidemiology of AD in children and the role of type 2 cytokines in driving the pathophysiology of the disease

View more
Current and Emerging Therapeutic Options for Children With Atopic Dermatitis
Dermatology
Current and Emerging Therapeutic Options for Children With Atopic Dermatitis
expert video

In this video of the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang reviews the current and emerging treatment options for children with AD uncontrolled with topical therapy, including a summary of recent long-term data for advanced systemic therapies

View more
Atopic Dermatitis in Children: Not Just a Skin Disease
Dermatology
Atopic Dermatitis in Children: Not Just a Skin Disease
expert video

In this video of the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Mark Boguniewicz discusses the multidimensional and cumulative disease burden of AD and its associated comorbidities in children. Dr Boguniewicz also highlights the burden experienced by caregivers of children with AD

View more
IL-4 Contributes to Systemic Type 2 Inflammation in AD
Dermatology
IL-4 Contributes to Systemic Type 2 Inflammation in AD
expert video

In this highlight video from the ADVENT AD symposium held at EADV’s 2024 Annual Meeting in Amsterdam, Dr. Stephan Weidinger discusses how IL-4 contributes to systemic type 2 inflammation in AD via several mechanisms, including T cell differentiation, B cell activation and IgE generation, and T regulatory cell inhibition.

View more
Type 2 Inflammation and Its Role in Atopic Dermatitis
Dermatology
Type 2 Inflammation and Its Role in Atopic Dermatitis
expert video

In this video of the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Christine Bangert reviews the epidemiology, clinical presentation, and differential diagnoses of AD in children, as well as the inflammatory processes driven by type 2 cytokines that lead to AD and its atopic comorbidities

View more
Key Treatment Considerations for Management of Atopic Dermatitis in Children
Dermatology
Key Treatment Considerations for Management of Atopic Dermatitis in Children
expert video

In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang reviews the key considerations for management of AD that is uncontrolled with topical therapies in children and the criteria to determine whether a patient is indicated for systemic therapy

View more
The Role of Type 2 Inflammation in Moderate-to-Severe AD
Dermatology
The Role of Type 2 Inflammation in Moderate-to-Severe AD
expert video

In this expert interview video focusing on topics from the September 2024 ADVENT symposium at EADV’s Annual Meeting in Amsterdam, the Netherlands, Dr. Stephan Weidinger discusses how type 2 inflammation contributes to the systemic inflammation seen in patients with moderate-to-severe AD.

View more
How Biologic Therapy May Lead to Disease Modification in Infants and Children With Atopic Dermatitis
Dermatology
How Biologic Therapy May Lead to Disease Modification in Infants and Children With Atopic Dermatitis
expert video

This full video presentation of the April 2025 WCPD symposium features Dr Amy Paller, Dr Paula Luna, and Dr Eulàlia Baselga. The faculty present the latest data on the possibility of achieving disease modification in infants and children with atopic dermatitis.

View more
Prevalence of Food Allergy and Other Atopic Comorbidities in Children With AD
Dermatology
Prevalence of Food Allergy and Other Atopic Comorbidities in Children With AD
expert video

In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Mark Boguniewicz discusses the prevalence of food sensitization and food allergy in pediatric patients with AD, clarifying the difference between the two. Dr Boguniewicz also discusses the prevalence of other atopic comorbidities in children with AD

View more
How Biologic Therapy May Lead to Disease Modification in Infants and Children with Atopic Dermatitis
Congress
8
April
2025
Congress
ADVENT at WCPD 2025

The ADVENT symposium at the 15th World Congress of Pediatric Dermatology (WCPD) will focus on discussions around disease modification in atopic dermatitis (AD) in three main topic areas: restoring the skin barrier, reducing non-atopic comorbidities, and stopping the atopic march in pediatric patients with AD aged 6 months to 11 years.

Identification and Management of AD Uncontrolled With Topical Therapies in Children
Dermatology
Identification and Management of AD Uncontrolled With Topical Therapies in Children
expert video

In this expert interview video focusing on topics from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang discusses how to identify pediatric patients with AD uncontrolled with topical therapies, considerations for the next step in care for these patients, and the potential benefits of early intervention with systemic treatment

View more